Title:
Carbazole carboxamide compounds useful as kinase inhibitors
Document Type and Number:
Japanese Patent JP6353530
Kind Code:
B2
Abstract:
Disclosed are compounds of Formula (I); and salts thereof, wherein: Formula (II); Q is: R1 is —C(CH3)2OH, —NHC(=0)C(CH3)3, —N(CH3)2, or —CH2Rd; R2 is CI or —CH3; R3 is H, F, or —CH3; Ra is H or —CH3; Rb is H, F, CI, or —OCH3 Rc is H or F; and Rd is —OH, —OCH3, —NHC(=0)CH3, or fORMULA (III), Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
More Like This:
Inventors:
Susung Ko
Douglas G Butt
Mira Board One Bertrand
George Budelka
Charles M Langvine
Genjie Liu
Anurag S Srivastava
Scott Hunter Watterson
Douglas G Butt
Mira Board One Bertrand
George Budelka
Charles M Langvine
Genjie Liu
Anurag S Srivastava
Scott Hunter Watterson
Application Number:
JP2016523870A
Publication Date:
July 04, 2018
Filing Date:
June 25, 2014
Export Citation:
Assignee:
BRISTOL-MYERS SQUIBB COMPANY
International Classes:
C07D403/10; A61K31/517; A61K31/519; A61P29/00; A61P37/02; A61P43/00; C07D471/04; C07D513/04
Domestic Patent References:
JP2012512888A |
Foreign References:
WO2011159857A1 |
Other References:
Lou, Yan et al.,Bruton's tyrosine kinase inhibitors: Approaches to potent and selective inhibition, preclinical and clinical evaluation for inflammatory diseases and B cell malignancies,Journal of Medicinal Chemistry,2012年,vol.55 no.10,pp.4539-4550
Attorney, Agent or Firm:
Samejima Mutsumi
Nagatoshi Shinagawa
Kure Hidenori
Nagatoshi Shinagawa
Kure Hidenori
Previous Patent: The tetrahydro carbazole and the carbazole Carboxamide compound which were replaced
Next Patent: BLURRING PREVENTIVE CAMERA
Next Patent: BLURRING PREVENTIVE CAMERA